Citation Tools
Immunotherapy biomarkers
Original research
CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers